Skip to content
DataLookout
Menu

DREAMSNCT07941466

Dose Reduced Alteplase in Managing Intrapleural Sepsis

StatusNot Yet Recruiting
PhasePhase 3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Treatment Success
Timeframe: From enrollment to standard treatment follow-up within 60 days following the first dose of intrapleural enzyme therapy

Arms and interventions

Reduced Dose Alteplase IETExperimental

Alteplase 4mg with 5mg DNase twice daily for six doses

Standard Dose Alteplase IETActive comparator

Alteplase 10mg with 5mg DNase twice daily for six doses

Drugs: Reduced Dose Alteplase, Standard Dose Alteplase